ArticleJAMA oncology2019
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors.
Jonathan Raphael Strosberg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleJAMA oncology2019
Jonathan Raphael Strosberg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.